应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
FBIO Fortress Biotech Inc.
未开盘 01-20 16:00:00 EST
3.48
-0.24
-6.45%
盘后
3.58
+0.10
+2.92%
19:46 EST
最高
3.65
最低
3.40
成交量
84.93万
今开
3.65
昨收
3.72
日振幅
6.72%
总市值
1.08亿
流通市值
8,182万
总股本
3,104万
成交额
296.28万
换手率
3.61%
流通股本
2,351万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Fortress Biotech与Cyprium Therapeutics宣布美国FDA批准Zycubo®(组氨酸铜),成为美国首个且唯一获批治疗门克斯病的疗法
美股速递 · 01-13
Fortress Biotech与Cyprium Therapeutics宣布美国FDA批准Zycubo®(组氨酸铜),成为美国首个且唯一获批治疗门克斯病的疗法
Journey Medical Corporation公布评估Emrosi™ (Dfd-29)对健康成年人微生物群影响的临床试验结果
美股速递 · 2025-12-10
Journey Medical Corporation公布评估Emrosi™ (Dfd-29)对健康成年人微生物群影响的临床试验结果
Fortress Biotech:Cyprium将在NDA批准后保留对任何PRV的所有权,并将获得版税以及高达1.29亿美元的里程碑付款
美股速递 · 2025-11-17
Fortress Biotech:Cyprium将在NDA批准后保留对任何PRV的所有权,并将获得版税以及高达1.29亿美元的里程碑付款
Fortress Biotech Inc.:在11月14日,Sentynl通知Cyprium已重新提交Cutx-101的NDA给FDA
美股速递 · 2025-11-17
Fortress Biotech Inc.:在11月14日,Sentynl通知Cyprium已重新提交Cutx-101的NDA给FDA
Fortress Biotech及其子公司Urica Therapeutics宣布Crystalys Therapeutics全球III期Dotinurad治疗痛风临床试验首位患者接受治疗
美股速递 · 2025-10-21
Fortress Biotech及其子公司Urica Therapeutics宣布Crystalys Therapeutics全球III期Dotinurad治疗痛风临床试验首位患者接受治疗
Fortress Biotech Inc.及其子公司Urica Therapeutics宣布Crystalys Therapeutics完成2.05亿美元A轮融资
美股速递 · 2025-10-01
Fortress Biotech Inc.及其子公司Urica Therapeutics宣布Crystalys Therapeutics完成2.05亿美元A轮融资
加载更多
公司概况
公司名称:
Fortress Biotech Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Fortress Biotech, Inc.于2006年6月28日在特拉华州注册成立。该公司是一家生物制药公司,专注于收购和推进资产,通过产品收入、股权持有以及股息和特许权使用费收入流为股东提升长期价值。
发行价格:
--
{"stockData":{"symbol":"FBIO","market":"US","secType":"STK","nameCN":"Fortress Biotech Inc.","latestPrice":3.48,"timestamp":1768942800000,"preClose":3.72,"halted":0,"volume":849270,"hourTrading":{"tag":"盘后","latestPrice":3.5815,"preClose":3.48,"latestTime":"19:46 EST","volume":5024,"amount":17715.3925,"timestamp":1768956372903,"change":0.1015,"changeRate":0.029167,"amplitude":0.04023},"delay":0,"changeRate":-0.06451612903225812,"floatShares":23511081,"shares":31037937,"eps":-0.293,"marketStatus":"未开盘","change":-0.24,"latestTime":"01-20 16:00:00 EST","open":3.65,"high":3.65,"low":3.4,"amount":2962830.754038,"amplitude":0.067204,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.293,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768986000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.72,"preHourTrading":{"tag":"盘前","latestPrice":3.62,"preClose":3.72,"latestTime":"09:24 EST","volume":13743,"amount":49627.150775099995,"timestamp":1768919069848,"change":-0.1,"changeRate":-0.026882,"amplitude":0.013441},"postHourTrading":{"tag":"盘后","latestPrice":3.5815,"preClose":3.48,"latestTime":"19:46 EST","volume":5024,"amount":17715.3925,"timestamp":1768956372903,"change":0.1015,"changeRate":0.029167,"amplitude":0.04023},"volumeRatio":0.312552,"impliedVol":1.5148,"impliedVolPercentile":0.8008},"requestUrl":"/m/hq/s/FBIO","defaultTab":"news","newsList":[{"id":"1193858645","title":"Fortress Biotech与Cyprium Therapeutics宣布美国FDA批准Zycubo®(组氨酸铜),成为美国首个且唯一获批治疗门克斯病的疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1193858645","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193858645?lang=zh_cn&edition=full","pubTime":"2026-01-13 20:46","pubTimestamp":1768308412,"startTime":"0","endTime":"0","summary":"Fortress Biotech Inc.与Cyprium Therapeutics联合宣布,其创新药物Zycubo®(组氨酸铜)已获得美国食品药品监督管理局(FDA)的正式批准。这一突破性疗法是美国境内首个且目前唯一获准用于治疗门克斯病的治疗方案,标志着罕见病治疗领域的一项重大进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"gpt_icon":0},{"id":"1153698516","title":"Journey Medical Corporation公布评估Emrosi™ (Dfd-29)对健康成年人微生物群影响的临床试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1153698516","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153698516?lang=zh_cn&edition=full","pubTime":"2025-12-10 21:31","pubTimestamp":1765373472,"startTime":"0","endTime":"0","summary":"Journey Medical Corporation公布了评估Emrosi™ (Dfd-29)对健康成年人微生物群影响的临床试验结果,结果已刊登在《皮肤病药物杂志》上。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DERM","FBIO","BK4007","BK4139"],"gpt_icon":0},{"id":"1115885695","title":"Fortress Biotech:Cyprium将在NDA批准后保留对任何PRV的所有权,并将获得版税以及高达1.29亿美元的里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1115885695","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115885695?lang=zh_cn&edition=full","pubTime":"2025-11-17 20:37","pubTimestamp":1763383035,"startTime":"0","endTime":"0","summary":"Fortress Biotech:Cyprium将在NDA批准后保留对任何PRV的所有权,并将获得版税以及高达1.29亿美元的里程碑付款","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"gpt_icon":0},{"id":"1126564189","title":"Fortress Biotech Inc.:在11月14日,Sentynl通知Cyprium已重新提交Cutx-101的NDA给FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=1126564189","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126564189?lang=zh_cn&edition=full","pubTime":"2025-11-17 20:33","pubTimestamp":1763382814,"startTime":"0","endTime":"0","summary":"Fortress Biotech Inc.:在11月14日,Sentynl通知Cyprium已重新提交Cutx-101的NDA给FDA","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"gpt_icon":0},{"id":"1130939272","title":"Fortress Biotech及其子公司Urica Therapeutics宣布Crystalys Therapeutics全球III期Dotinurad治疗痛风临床试验首位患者接受治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1130939272","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130939272?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:31","pubTimestamp":1761049870,"startTime":"0","endTime":"0","summary":"Fortress Biotech及其子公司Urica Therapeutics宣布,Crystalys Therapeutics正在进行的全球III期Dotinurad治疗痛风的临床试验首位患者已完成用药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBIO"],"gpt_icon":0},{"id":"1158296044","title":"Fortress Biotech Inc.及其子公司Urica Therapeutics宣布Crystalys Therapeutics完成2.05亿美元A轮融资","url":"https://stock-news.laohu8.com/highlight/detail?id=1158296044","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158296044?lang=zh_cn&edition=full","pubTime":"2025-10-01 20:06","pubTimestamp":1759320378,"startTime":"0","endTime":"0","summary":"Fortress Biotech Inc.及其子公司Urica Therapeutics宣布Crystalys Therapeutics完成2.05亿美元A轮融资","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fortressbiotech.com","stockEarnings":[{"period":"1week","weight":-0.1077},{"period":"1month","weight":-0.0169},{"period":"3month","weight":0.3701},{"period":"6month","weight":0.7938},{"period":"1year","weight":0.861},{"period":"ytd","weight":-0.0492}],"compareEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0044},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.068},{"period":"1year","weight":0.1339},{"period":"ytd","weight":-0.0064}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fortress Biotech, Inc.于2006年6月28日在特拉华州注册成立。该公司是一家生物制药公司,专注于收购和推进资产,通过产品收入、股权持有以及股息和特许权使用费收入流为股东提升长期价值。","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":0.075472},{"month":2,"riseRate":0.6,"avgChangeRate":0.010779},{"month":3,"riseRate":0.4,"avgChangeRate":-0.009436},{"month":4,"riseRate":0.4,"avgChangeRate":-0.006403},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.025034},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.018965},{"month":7,"riseRate":0.545455,"avgChangeRate":-0.008162},{"month":8,"riseRate":0.545455,"avgChangeRate":0.05815},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.057104},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.163485},{"month":11,"riseRate":0.818182,"avgChangeRate":0.114632},{"month":12,"riseRate":0.545455,"avgChangeRate":0.07644}],"exchange":"NASDAQ","name":"Fortress Biotech Inc.","nameEN":"Fortress Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fortress Biotech Inc.(FBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fortress Biotech Inc.,FBIO,Fortress Biotech Inc.股票,Fortress Biotech Inc.股票老虎,Fortress Biotech Inc.股票老虎国际,Fortress Biotech Inc.行情,Fortress Biotech Inc.股票行情,Fortress Biotech Inc.股价,Fortress Biotech Inc.股市,Fortress Biotech Inc.股票价格,Fortress Biotech Inc.股票交易,Fortress Biotech Inc.股票购买,Fortress Biotech Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fortress Biotech Inc.(FBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}